Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05918809
Status:
COMPLETED
Last Update Posted:
2023-06-26
First Post:
2023-06-16
Brief Title:
Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma DLBCL Inpatient and Outpatient Settings
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diffuse Large B-cell Lymphoma |
Keywords: